BioSpace News Archive

Ten new Ohio schools received STEM/STEAM School Designation. The Ohio STEM Committee approved applications for schools that implement best practices in STEM and STEAM education.

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 17th Annual Craig Hallum Institutional Investor Conference taking place on Wednesday, May 27, 2020. Misonix President and Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Misonix

The Boettcher Foundation has selected eight researchers to receive funding through the Boettcher Foundation’s Webb-Waring Biomedical Research Awards Program. The recipients, known as Boettcher Investigators, represent five of Colorado’s top research institutions: Colorado College, Colorado State University, National Jewish Health, University of Colorado Ansch

Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report on Form 10-Q announcing financial results for the quarter ended March 31, 2020.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company that applies its Nucleosomics TM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced today the closing of its previously announced underw

- A New Class of Female-Controlled Birth Control for Use In-The-Moment - - Robust Telemedicine Program Will Support Access for Women - - Company to Host Conference Call on Tuesday, May 26, 2020 at 8:30 a.m. ET -

vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that it will host its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) as a virtual-only meeting that will be held via live audio webcast due to the public health and safety concerns related to the COVID-19 pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others. The pre

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received its NPN (Natural Product Number) from Health Canada. Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

AbCellera announced today that it has entered into a multi-year strategic research collaboration and license agreement with Eli Lilly and Company (Lilly) on the discovery of antibodies for up to nine Lilly-selected therapeutic targets.

Dupixent demonstrated significant clinical and anatomic improvements, including the ability to swallow, in Part A of pivotal trial